• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Cumulative number of compliance actions/cases supported by WGS (in conjunction with OAO)

Dictionary: The GenomeTrakr Program is creating a sustainable network of public health laboratories using whole genome sequencing (WGS) to investigate foodborne illness outbreaks and attribute illnesses to specific food products, processing or farming practices, or geographic regions. The program is changing the way that foodborne illnesses are investigated, allowing authorities to investigate small illness clusters before there is a chance to sicken large numbers of people. The network is linked by a common, publically-accessible database that uses a common sequencing platform, with common laboratory and quality control procedures, common on-board training and a common metadata (sample information) standard. Since 2012, the network has expanded to 10 state health and agriculture laboratories, one commercial lab servicing the food industry, and one international lab. The network has built a database of over 10 thousand and 4 thousand Salmonella and Listeria monocytogenes genomes respectively from real time surveillance and historical collections. This database has supported multiple foodborne illness outbreak investigations and is fundamentally changing the way that outbreak investigations are conducted.

Information is current as of March 31, 2023.

Fiscal Year - 2023

Skip graphic and jump to text data

Oct - Dec 2022N/A1,107
Jan - Mar 2023N/A1,144
Apr - Jun 2023N/ATBD
Jul - Sept 2023N/ATBD

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.